Medicago announces publication of Phase 3 COVID-19 vaccine study results in New England Journal of Medicine - Canada NewsWire

/CNW/ - Medicago today announced the publication of the results from the Phase 3 study of COVIFENZ®, COVID-19 vaccine (plant-based virus-like particles [VLP],...

Study results were included in the submission to Health Canada leading to Notice of Compliance QUEBEC CITY, May 5, 2022 /CNW/ - Medicago today announced the publication of the results from the Phase… [+3458 chars]

full article...